INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Address
1100 CAMPUS ROAD
PRINCETON, NJ 08540
Founded
1989
Number of Employees
5,329
Website
http://www.integralife.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | - | $125,002 | $430,949 | $49,998 | $201,983 |
Average Price | - | - | - | - | - | - | - | - | $64.50 | $53.49 | $39.27 | $53.78 |
# Shares Purchased | - | - | - | - | - | - | - | - | 1,938,010 | 8,056,619 | 1,273,190 | 3,755,940 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | - | - | - | - | - | - | - | - | -73.6% | -68.2% | -56.7% | -68.4% |
S&P 500 Return to Date | - | - | - | - | - | - | - | - | 37.3% | 31.3% | 7.4% | 25.3% |
Excess Total Return | - | - | - | - | - | - | - | - | -110.9% | -99.6% | -64.1% | -93.7% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | - | - | - | - | - | - | - | - | 5% | 3% | 2% | 8% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)